Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer

• المؤلفون الرئيسيون: Chitapanarux I., Tonusin A., Sukthomya V., Charuchinda C., Pukanhapan N., Lorvidhaya V.
• التنسيق: مقال
• اللغة: English
• منشور في: 2014
• الوصول للمادة أونلاين: http://www.scopus.com/inward/record.url?eid=2-s2.0-0037498599&partnerID=40&md5=cbad447c75d91093ef9e07786e05f916; http://www.ncbi.nlm.nih.gov/pubmed/12798702; http://cmuir.cmu.ac.th/handle/6653943832/3112

Objective. The goal of this study was to evaluate the efficacy and tolerability of irinotecan plus cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer. Methods. Chemotherapy-naive patients with metastatic or recurrent disease and at least one measurable tumor site receive...